MARKET

OMCL

OMCL

Omnicell Com
NASDAQ
27.86
+0.73
+2.69%
After Hours: 27.86 0 0.00% 16:20 04/26 EDT
OPEN
27.27
PREV CLOSE
27.13
HIGH
28.28
LOW
27.27
VOLUME
393.19K
TURNOVER
0
52 WEEK HIGH
77.14
52 WEEK LOW
25.69
MARKET CAP
1.28B
P/E (TTM)
-61.8287
1D
5D
1M
3M
1Y
5Y
Clover Health Appoints Peter Kuipers As Chief Financial Officer, Effective As Of The Day After The Filing Of The Co's Quarterly Report On Form 10-Q For The Quarter-Ended March 31, 2024
Clover Health Investments, Corp. Appoints Peter Kuipers as Chief Financial Officer. Mr. Kuipers brings over 25 years of technology leadership experience to the CFO role at Clover. He is the former Executive Vice President and CFO at Omnicell, Inc., a healthcare technology company. He will be responsible for overseeing all financial aspects of the Company.
Benzinga · 4d ago
Weekly Report: what happened at OMCL last week (0415-0419)?
Weekly Report · 4d ago
Peek Under The Hood: VIOO Has 18% Upside
NASDAQ · 04/19 11:02
Shareholders in Omnicell (NASDAQ:OMCL) have lost 81%, as stock drops 4.3% this past week
Omnicell, Inc. Shareholders have lost 56% in the last year. The company's share price has declined 81% over the last three years. The stock has lost 4.3% in just the past week. Omnicell has seen a drop in its share price over the past year. Insider buying has been high in the past 12 months for the company.
Simply Wall St · 04/18 10:49
Omnicell (OMCL) Receives a Buy from Craig-Hallum
TipRanks · 04/17 12:55
Omnicell’s Strategic Shift to Recurring Revenue: A Cautious Hold Amidst Transformation Uncertainty
TipRanks · 04/17 09:07
Omnicell Announces XT Amplify, A Multi-Year Innovation Program That Is Intended To Maximize Value For Hospitals, Health Systems, And Post-Acute Care Facilities That Have Invested In Omnicell's XT Automated Dispensing System
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell, Inc. Announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities. The solutions are intended to enhance nursing efficiency and reduce medication errors and waste. The first set of solutions will be available in North America.
Benzinga · 04/16 20:14
Weekly Report: what happened at OMCL last week (0408-0412)?
Weekly Report · 04/15 09:19
More
About OMCL
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Webull offers Omnicell Inc stock information, including NASDAQ: OMCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMCL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OMCL stock methods without spending real money on the virtual paper trading platform.